Dr. Eitan was the first to study exosomes at the National Institute on Aging (NIA). As a pioneer in the field, Dr. Eitan has developed novel methodologies and published over 27 peer reviewed articles. Prior to founding NeuroDex, Dr. Eitan served as senior scientist in a leading diagnostic company, Dr. Eitan has led research collaborations with several pharmaceutical companies, as well as academia.
Oded is an experienced executive in the diagnostics space, and specializes in business development, financing, and corporate strategy. Oded led the business development and operations of Rosetta Genomics from 2011 to 2016. Oded also co-led the financing efforts resulting in over $60M in funding in the course of one year. Oded is an attorney with over 15 years of experience in corporate, securities, and contract law.
Dr. Nir is a scientist, entrepreneur, and angel investor with over 28 years of experience in the commercialization of recombinant cytokines and pre-clinical contract research services. Dr. Nir is the co-founder of two preclinical Contract Research Organizations, three biotechnology companies (one publicly traded), a diagnostic company, a venture company and an incubator company, which operates 2 new bio-incubators in Natick, MA. Since 1997, Dr. Nir has served as President and CSO of SBH Sciences, where he manages all R&D and business activities.
